StockNews.com assumed coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report report published on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Stock Performance Shares of OPGN opened at $0.47 on Wednesday. The company’s 50-day simple moving average is $0.57 and its 200-day simple moving […]
StockNews.com began coverage on shares of OpGen (NASDAQ:OPGN – Free Report) in a research report sent to investors on Wednesday. The brokerage issued a sell rating on the medical research company’s stock. OpGen Trading Down 3.1 % OPGN opened at $0.47 on Wednesday. The company has a market capitalization of $5.93 million, a price-to-earnings ratio […]
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) saw a large increase in short interest in March. As of March 31st, there was short interest totalling 2,230,000 shares, an increase of 10,621.2% from the March 15th total of 20,800 shares. Based on an average daily trading volume, of 1,670,000 shares, the short-interest ratio is currently 1.3 […]
OpGen, Inc. (NASDAQ:OPGN – Get Free Report) was the recipient of a significant drop in short interest in March. As of March 15th, there was short interest totalling 20,800 shares, a drop of 47.3% from the February 29th total of 39,500 shares. Based on an average daily trading volume, of 1,470,000 shares, the short-interest ratio […]
HC Wainwright reaffirmed their buy rating on shares of Precigen (NASDAQ:PGEN – Free Report) in a report issued on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 price target on the biotechnology company’s stock. HC Wainwright also issued estimates for Precigen’s Q1 2024 earnings at ($0.09) EPS, Q2 2024 earnings at ($0.09) EPS, Q3 […]